BASF India Q2 FY27 Results (NSE: BASF)

· Analysis by Alpha Inflection

Signal: Margin pressure

The read

The Q2FY27 inflection is negative after Q1FY27's margin recovery: revenue grew 23.8% YoY, but implied EBITDA margin fell to 2.6% from 4.6% and standalone PAT fell 38.9% to ₹617.1 million. The dominant issue is a 251bps gross-margin compression, with three segments moving into losses despite Industrial Solutions and Nutrition & Care improving.

BASF India Q2 FY27 key financials
MetricValueYoYQoQ
Revenue₹4,832.19 Cr+24.0%+0.2%
EBIT₹85.61 Cr-40.4%
EBIT margin2.6%

P&L walk

Consolidated revenue increased to ₹48,321.9 million, +24.0% YoY and +0.2% QoQ, but the implied EBITDA margin fell to 2.6% from 4.6% as cost of materials, purchases and inventory movements absorbed the revenue growth; the supplied extract does not include consolidated total PAT or EPS after the continuing-operations line.

Segments

Industrial Solutions generated ₹835.8 million of segment result, up 80.2% YoY, and Nutrition & Care generated ₹655.1 million versus ₹93.0 million; these gains were outweighed by Agricultural Solutions turning to a ₹286.3 million loss, Materials turning to a ₹4.5 million loss and Chemicals turning to an ₹81.1 million loss.

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.